PATH-MBM: Sequencing nivolumab plus ipilimumab and BRAF/MEK therapy in melanoma brain metastases—a real-world analysis (SNO 2026) - Sep 9, 2026 - Abstract #NCOG-47; Pres time: Nov 13, 2026; 07:30 PM - 09:30 PM; Location: Exhibit Hall D & E; No abstract available
Clinical • Real-world • Real-world evidence • Melanoma • Solid Tumor • BRAF
|
|
Zouina Sarfraz; Fatma Nihan Akkoc Mustafayev; Lydia Hodgson; Andrea McCracken; Charlie Hurmiz; Suresh Marada; Matthew J. Shepard; Manmeet S. Ahluwalia
|